By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Arbutus Biopharma (Formerly Known As Tekmira Pharmaceuticals Corporation) 

3805 Old Easton Road
Doylestown, PA 18902

8900 Glenlyon Parkway

Burnaby,  British Columbia,  V5J 5J8  Canada
Phone: 604-419-3200 Fax: 604-419-3201


Arbutus Biopharma Corporation is a publicly-traded (NASDAQ: ABUS) biopharmaceutical company dedicated to discovering, developing and commercializing a cure for patients suffering from chronic hepatitis B infection, a disease of the liver caused by hepatitis B virus (HBV). We are developing a portfolio of drug candidates with multiple mechanisms of action that we believe will result in a combination therapy that will transform the HBV treatment landscape and cure hepatitis B virus disease.

In addition to our HBV Assets, we are developing a pipeline of oncology, anti-viral and metabolic programs that leverage our expertise in RNA interference (RNAi) therapeutics and our Lipid Nanoparticle (LNP) technology.

Key Statistics

Ownership: Public

Web Site: Arbutus Biopharma
Employees: <500 Employees
Symbol: ABUS

Company News
Arbutus Biopharma (ABUS) Says HCC Candidate Was Well Tolerated in Phase I Trial, Seeks Partner to Enable Further Studies 7/20/2016 6:14:54 AM
Arbutus Biopharma (ABUS) To Present Data On New LNP Formulations For Delivery Of mRNA At The 2016 Controlled Release Society Conference 7/19/2016 8:16:15 AM
NeuroVive (NVP) Announces Arbutus Biopharma (ABUS)’s Notice Of Termination 7/6/2016 10:05:04 AM
Arbutus Biopharma (ABUS) To Present mRNA Delivery Data At The 32nd Annual Meeting Of The Japan Society Of Drug Delivery System 6/30/2016 9:23:42 AM
Arbutus Biopharma (ABUS) To Participate In Upcoming Investor Conferences 6/3/2016 7:55:17 AM
Arbutus Biopharma (ABUS) To Present At The 5th Antiviral Drugs Research And Development Conference 6/1/2016 8:21:43 AM
Arbutus Biopharma (ABUS) Provides Corporate Update And Announces First Quarter 2016 Financial Results 5/5/2016 8:17:11 AM
Arbutus Biopharma (ABUS) Expands HBV Pipeline 5/4/2016 7:48:38 AM
Arbutus Biopharma (ABUS) To Provide A Corporate Update And Release First Quarter 2016 Financial Results 4/29/2016 10:21:14 AM
Arbutus Biopharma (ABUS) To Participate In Upcoming Investor Conferences 4/28/2016 8:13:00 AM